These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30909009)

  • 1. Evaluation of the Elecsys
    Anckaert E; Denk B; He Y; Torrance HL; Broekmans F; Hund M
    Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():133-138. PubMed ID: 30909009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist? A retrospective single-center study.
    Polyzos NP; Nelson SM; Stoop D; Nwoye M; Humaidan P; Anckaert E; Devroey P; Tournaye H
    Fertil Steril; 2013 Aug; 100(2):438-44. PubMed ID: 23602319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of ovarian response using the automated Elecsys anti-Müllerian hormone assay in gonadotrophin-releasing hormone antagonist cycles.
    Bosch E; Labarta E; Zuzuarregui J; Iliodromiti S; Nelson SM
    Reprod Biomed Online; 2023 Feb; 46(2):295-301. PubMed ID: 36522281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET.
    Tsakos E; Tolikas A; Daniilidis A; Asimakopoulos B
    Arch Gynecol Obstet; 2014 Dec; 290(6):1249-53. PubMed ID: 25001569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The performance of the Elecsys® anti-Müllerian hormone assay in predicting extremes of ovarian response to corifollitropin alfa.
    Neves AR; Blockeel C; Griesinger G; Garcia-Velasco JA; Marca A; Rodriguez I; Drakopoulos P; Alvarez M; Tournaye H; Polyzos NP
    Reprod Biomed Online; 2020 Jul; 41(1):29-36. PubMed ID: 32466992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Müllerian hormone for the assessment of ovarian response in GnRH-antagonist-treated oocyte donors.
    Polyzos NP; Stoop D; Blockeel C; Adriaensen P; Platteau P; Anckaert E; Smitz J; Devroey P
    Reprod Biomed Online; 2012 May; 24(5):532-9. PubMed ID: 22417669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the value of anti-Müllerian hormone in predicting the response to ovarian stimulation with GnRH agonist and antagonist protocols?
    Knez J; Kovačič B; Medved M; Vlaisavljević V
    Reprod Biol Endocrinol; 2015 Jun; 13():58. PubMed ID: 26059906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of the lower serum anti-Müllerian hormone threshold for ovarian stimulation prior to in-vitro fertilization using the Elecsys® AMH assay: a prospective observational study.
    Grynnerup AG; Løssl K; Pilsgaard F; Lunding SA; Storgaard M; Bogstad JW; Prætorius L; Zedeler A; Bungum L; Nyboe Andersen A; Pinborg A
    Reprod Biol Endocrinol; 2019 Jan; 17(1):11. PubMed ID: 30634990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of antral follicle count and serum anti Müllerian hormone level for determination of gonadotropin dosing in in-vitro fertilization: randomized trial.
    Li HWR; Ko JKY; Lee VCY; Yung SSF; Lau EYL; Yeung WSB; Ho PC; Ng EHY
    Ultrasound Obstet Gynecol; 2020 Mar; 55(3):303-309. PubMed ID: 31325336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Müllerian hormone.
    Hamdine O; Eijkemans MJ; Lentjes EW; Torrance HL; Macklon NS; Fauser BC; Broekmans FJ
    Hum Reprod; 2015 Jan; 30(1):170-8. PubMed ID: 25355590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The addition of anti-Müllerian hormone in an algorithm for individualized hormone dosage did not improve the prediction of ovarian response-a randomized, controlled trial.
    Magnusson Å; Nilsson L; Oleröd G; Thurin-Kjellberg A; Bergh C
    Hum Reprod; 2017 Apr; 32(4):811-819. PubMed ID: 28175316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Müllerian hormone levels to predict oocyte maturity and embryo quality during controlled ovarian hyperstimulation.
    Melado Vidales L; Fernández-Nistal A; Martínez Fernández V; Verdú Merino V; Bruna Catalán I; Bajo Arenas JM
    Minerva Ginecol; 2017 Jun; 69(3):225-232. PubMed ID: 27352270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment.
    Andersen AN; Witjes H; Gordon K; Mannaerts B;
    Hum Reprod; 2011 Dec; 26(12):3413-23. PubMed ID: 21954280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is AMH useful to reduce low ovarian response to GnRH antagonist protocol in oocyte donors?
    Martínez F; Clua E; Carreras O; Tur R; Rodríguez I; Barri PN
    Gynecol Endocrinol; 2013 Aug; 29(8):754-7. PubMed ID: 23758138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN; Phung HT; Ho MT
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors for ovarian response in a corifollitropin alfa/GnRH antagonist protocol for controlled ovarian stimulation in IVF/ICSI cycles.
    Oehninger S; Nelson SM; Verweij P; Stegmann BJ
    Reprod Biol Endocrinol; 2015 Oct; 13():117. PubMed ID: 26520396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.
    Lee JR; Kim SH; Kim SM; Jee BC; Ku SY; Suh CS; Choi YM; Kim JG; Moon SY
    Fertil Steril; 2008 Apr; 89(4):860-7. PubMed ID: 18249372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential response of AMH to GnRH agonist among individuals: the effect on ovarian stimulation outcomes.
    Cai J; Liu L; Zheng J; Zhang L; Jiang X; Li P; Sha A; Ren J
    J Assist Reprod Genet; 2018 Mar; 35(3):467-473. PubMed ID: 29264688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of prognostic modelling of high and low ovarian response to ovarian stimulation for IVF.
    Scheinhardt MO; Lerman T; König IR; Griesinger G
    Hum Reprod; 2018 Aug; 33(8):1499-1505. PubMed ID: 30007353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal cutoff value of basal anti-mullerian hormone in iranian infertile women for prediction of ovarian hyper-stimulation syndrome and poor response to stimulation.
    Aghssa MM; Tarafdari AM; Tehraninejad ES; Ezzati M; Bagheri M; Panahi Z; Mahdavi S; Abbasi M
    Reprod Health; 2015 Sep; 12():85. PubMed ID: 26357853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.